By: Shruti Tripathi

I am City A.M.'s news editor. I love interviewing entrepreneurs, carrying out investigations through freedom of information requests and covering all the latest goings on in the world's great city, London. I started my career as an intern at LondonLovesBusiness.com in 2011 and became editor in 2015. I joined City A.M. as deputy night editor in July 2016.

All 463 Articles

London’s mid-sized businesses must not be overlooked in Brexit talks

February 27, 2017

London's mid-sized firms risk being overlooked during Britain’s departure from the European Union, according to new research published by BDO. The accountancy firm is calling on the government to take into account the needs of London’s mid-sized firms during Brexit negotiations. The report claims mid-sized firms are driving more growth in the UK than the [...]
Alibaba and a Californian school set to make millions from Snap’s IPO

February 26, 2017

Chinese e-commerce giant Alibaba and a Californian school stand to make millions of dollars from Snap's IPO this week. In what will be one of the tech industry's biggest floats to date, social media giant Snap is set to make its Wall Street debut this week with hopes to raise $3bn (£2.41bn). Snap, the company [...]
One of UK’s fastest-growing companies just bought Startups.co.uk for nearly £1m

February 26, 2017

One of the UK's fastest-growing tech companies has snapped up UK business advice website Startups.co.uk for nearly £1m. Startups was founded by David Lester in 2000. Following the acquisition, he will step down and will focus on his HR start-up citrusHR. The Startups team, which boasts 4.8m readers, will join over 300 people at MVF’s North London [...]
Intu boss David Fischel : The UK is way out of line with its international peers on business rates

February 23, 2017

Intu ruled the FTSE 100 roost this morning after the shopping centre giant increased its dividend, despite reporting a fall in profits. The retail property group's profits dropped more than 60 per cent but its dividend was up two per cent, at 14p per share. Revenues grew four per cent to £594.3m, from £571.6m the year before. While [...]
Zest for pests: Rentokil Initial’s profits creep up after 41 acquisitions worth £107m

February 23, 2017

Rat-catcher and business services group Rentokil Initial's pre-tax profit crept up last year on the back of 41 acquisitions worth £107m. For the year to the end of December, the FTSE 250 firm's pre-tax profit stood at £208.5m from £159m the year before. Revenue hit £2.17bn, up from £1.8bn in the previous year. Rentokil Initial acquired 41 companies in 2016 for [...]
Westfield’s profits drop despite shoppers flocking to Westfield London and Stratford City

February 23, 2017

Australian shopping mall behemoth Westfield has announced a fall in profits in its full-year results but its London centres attracted more shoppers in 2016. Westfield London and Stratford City generated combined annual sales of around £2.2bn from 75m customer visits, the company said. The shopping centre firm’s net profit for the year stood at $1.3bn (£1.09bn) [...]
AO World founder John Roberts has stepped down as CEO – here’s who’s replacing him

February 22, 2017

John Roberts, the founder of British online electrical retailer AO World, has stepped down as chief executive but will remain on the board. Steve Caunce, the retailer's chief operating officer, will replace Roberts as CEO. Earlier this week, Morgan Stanley downgraded AO World saying its overall growth in the UK will be weak over the next few [...]
FTSE-250 drug firm looking pale after $220m litigation charge

February 22, 2017

FTSE-250 drug company Indivior's full-year pre-tax profits have taken a beating from a $220m (£176m) litigation charge. The drug firm, which makes addiction treatment drugs, saw pre-tax profit fall to $98m from $285m for the year to the end of December. The company recorded a charge of $220m in the third quarter of 2016 for investigative and [...]
Astrazeneca to sell commercial rights of cancer drug in $320m deal

February 20, 2017

AstraZeneca has struck a $320m (£256m) deal with TerSera Therapeutics to sell the commercial rights of its Zoladex cancer treatment in the US and Canada. Zoladex is an injectable drug used to treat malignant prostate and breast cancer. As part of the deal, AstraZeneca will receive sales-related income through milestones totalling up to $70m. In 2016, product sales for Zoladex were $69m in the [...]
Check out: 1,800 hotel firms could go bust in the next three years

February 20, 2017

Nearly 2,000 UK hotel companies could go bust over the next three years as a result of the Brexit vote, according to new research from accountancy firm Moore Stephens. The accountancy firm predicts 1,800 UK hotel companies have at least a 30 per cent chance of going insolvent within the next three years as food and beverage [...]

World Triathlon targets T100 Olympic event as soon as Brisbane 2032

World Triathlon targets T100 Olympic event as soon as Brisbane 2032

The history of Christmas dinner, from steamed sheep’s head to traditional turkey

By: Shruti Tripathi

All 463 Articles

Subscribe